𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Recombinant human granulocyte-colony stimulating factor and recombinant human macrophage colony stimulating factor synergize in vivo to enhance proliferation of granulocyte-macrophage, erythroid, and multipotential progenitor cells in mice

✍ Scribed by Hal E. Broxmeyer; Douglas E. Williams; Scott Cooper; Giao Hangoc; Peter Ralph


Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
579 KB
Volume
38
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis


Combinations of low dosages of purified recombinant human (rh) macrophagecolony stimulating factor (M-CSF; also termed CSF-1) and rh granulocyte-colony stimulating factor (G-CSF) were compared alone and in combination for their influence on the cycling rates and numbers of bone marrow and splenic granulocyte-macrophage, erythroid, and multipotential progenitor cells in vivo in mice pretreated with iron-saturated human lactoferrin (LF). LF was used to enhance detection of the stimulating effects of exogenously added CSFs. Concentrations of each CSF that were not active in vivo when given alone were active when given together, with the other CSF. The concentrations of rhM-CSF and rhG-CSF needed to increase progenitor cell cycling in the marrow and spleen were reduced by factors of 40-200 when these CSFs were administered in combination with low dosages of the other CSF. At the concentrations of rhM-CSF and rhG-CSF tested, synergism was not noted on absolute numbers of progenitor cells or total nucleated cell counts per organ or circulating in the blood. These findings may


πŸ“œ SIMILAR VOLUMES


Recombinant human granulocyte macrophage
✍ Dr A. M. Oza; M. Leahy; E. Dorey; C. L. Davis; J. Amess; M. Horton; A. Z. S. Roh πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 613 KB

Fourteen patients with Hodgkin's disease (two previously untreated, 12 following relapse or with refractory disease) were treated with a combination chemotherapy regimen comprising chlorambucil, vinblastine, procarbazine, prednisolone, etoposide, vincristine and adriamycin administered on days 1-8.

Pilot study of recombinant human granulo
✍ Julio Martin; Orencio Bosch; Gloria Moraleda; Javier Bartolome; Juan Antonio Qui πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 593 KB

is a fellow of Ministerio de Educaci6n y Ciencia. J. Bartolome and J.A. Quiroga are recipients of research grants from Fundacion para el Estudio de las Hepatitis Vudes.